APA (7th ed.) Citation

SJ, B., D, G., PB, S., WG, P., A, S., A, K., . . . Jr, B. D. (2025). Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM). Journal of clinical pharmacology, 65(11), 1497. https://doi.org/10.1002/jcph.70057

Chicago Style (17th ed.) Citation

SJ, Balevic, et al. "Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM)." Journal of Clinical Pharmacology 65, no. 11 (2025): 1497. https://doi.org/10.1002/jcph.70057.

MLA (9th ed.) Citation

SJ, Balevic, et al. "Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM)." Journal of Clinical Pharmacology, vol. 65, no. 11, 2025, p. 1497, https://doi.org/10.1002/jcph.70057.